… 2 inhibition on tubular injury markers. Our data demonstrate that dapagliflozin does not increase
tubular injury markers… kidney injury markers indicates that 6-weeks dapagliflozin therapy …

… is an early marker for acute kidney injury … a marker for drug-induced renal injury. One report
indicated that urine NAG increased after sergliflozin treatment, which is an SGLT2 inhibitor …

… We evaluated whether dapagliflozin reduces renal damage in IR mice model. In addition, …
In conclusion, dapagliflozin attenuates renal IR injury. HIF1 induction by dapagliflozin may …

… and accentuate inflammation after tissue injury, but they are … dapagliflozin or phlorizin
administration leads to inhibitory responses on M1 markers and stimulatory effects on M2 markers…

… that dapagliflozin treatment to ameliorate renal injury was … expression of NGAL, a renal injury
marker, and TGF-β1 and … , the improved renal injury observed in the HFD-fed, dapagliflozin-…

… The SGLT2 inhibitor dapagliflozin significantly improves the peripheral microvascular
endothelial function in patients with uncontrolled type 2 diabetes mellitus. Intern Med 2018;57:2147…

… in the number of podocytes labeled for the specific marker Wilms’ tumor 1 (WT1) was found,
… conditions, suggested that stress/injury modulated the activity of glucose transporters other …

… at 0.1 to 5 μM shows a significant protective effect against oxidative stress-induced cell injury.
Both H 2 O 2 -induced apoptosis and cell growth inhibition are alleviated by dapagliflozin. …

… In our study, dapagliflozin had an inhibitory effect on the upstream protein HIF-1α and …
expression of NF-κB and caspase-3, which is a marker of cellular apoptosis. We also found that …

… (b) Dapagliflozin (DAPA), the inhibitor having higher affinity for SGLT2, is able to prevent
the characteristics of the mechanically provoked biomarkers for cardiac injury. As a result, …